Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species. | Elife | 2022 | 35535493 | PubTator, text mining | PubMed |
| Novel animal model of combined generalized and focal epilepsy. | Epilepsia | 2022 | 35532890 | PubTator, text mining | PubMed |
| The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context. | Front Oncol | 2022 | 35530337 | PubTator, text mining | PubMed |
| [Construction and identification of a HEK293 cell line with stable TrxR1 overexpression]. | Nan Fang Yi Ke Da Xue Xue Bao | 2022 | 35527491 | PubTator, text mining | PubMed |
| Diallyl disulfide ameliorates ethanol-induced liver steatosis and inflammation by maintaining the fatty acid catabolism and regulating the gut-liver axis. | Food Chem Toxicol | 2022 | 35526736 | PubTator, text mining | PubMed |
| Airway Macrophages Encompass Transcriptionally and Functionally Distinct Subsets Altered by Smoking. | Am J Respir Cell Mol Biol | 2022 | 35522264 | PubTator, text mining | PubMed |
Application of two-dimensional difference gel electrophoresis to identify protein changes between center, margin, and adjacent non-tumor tissues obtained from non-small-cell lung cancer with adenocarcinoma or squamous cell carcinoma subtype. | PLoS One | 2022 | 35512017 | PubTator, text mining | PubMed |
| Crotamiton derivative JM03 extends lifespan and improves oxidative and hypertonic stress resistance in Caenorhabditis elegans via inhibiting OSM-9. | Elife | 2022 | 35510610 | PubTator, text mining | PubMed |
| Selenium Metabolism and Biosynthesis of Selenoproteins in the Human Body. | Biochemistry (Mosc) | 2022 | 35501994 | PubTator, text mining | PubMed |
| Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma. | Comput Struct Biotechnol J | 2022 | 35495118 | PubTator, text mining | PubMed |
| Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death. | Invest Ophthalmol Vis Sci | 2022 | 35486068 | PubTator, text mining | PubMed |
| MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis. | Nat Cancer | 2022 | 35484422 | PubTator, text mining | PubMed |
| Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway. | J Int Med Res | 2022 | 35481419 | PubTator, text mining | PubMed |
| Subtype-Specific Surface Proteins on Adipose Tissue Macrophages and Their Association to Obesity-Induced Insulin Resistance. | Front Endocrinol (Lausanne) | 2022 | 35480482 | PubTator, text mining | PubMed |
| Plasma Proteomic Profile of Patients with Tick-Borne Encephalitis and Co-Infections. | Int J Mol Sci | 2022 | 35457192 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway Genes. | Pharmaceuticals (Basel) | 2022 | 35455458 | PubTator, text mining | PubMed |
| The Selenoprotein Glutathione Peroxidase 4: From Molecular Mechanisms to Novel Therapeutic Opportunities. | Biomedicines | 2022 | 35453641 | PubTator, text mining | PubMed |
| Antioxidant and Anticancer Activities of Synthesized Methylated and Acetylated Derivatives of Natural Bromophenols. | Antioxidants (Basel) | 2022 | 35453471 | PubTator, text mining | PubMed |
| Piperlongumine Inhibits Thioredoxin Reductase 1 by Targeting Selenocysteine Residues and Sensitizes Cancer Cells to Erastin. | Antioxidants (Basel) | 2022 | 35453395 | PubTator, text mining | PubMed |
| The BCAT1 CXXC Motif Provides Protection against ROS in Acute Myeloid Leukaemia Cells. | Antioxidants (Basel) | 2022 | 35453368 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=58